Hainan Haiyao Overview

  • Year Founded
  • 1965

Year Founded

  • Status
  • Public

  • Employees
  • 1,738

Employees

  • Stock Symbol
  • 000566

Stock Symbol

  • Investments
  • 4

  • Share Price
  • $0.59
  • (As of Friday Closing)

Hainan Haiyao General Information

Description

Hainan Haiyao Co Ltd is engaged in the research, development, production, and sales of pharmaceuticals and medical devices.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • No. 192, Nanhai Avenue
  • Xiuying District
  • Haikou, Hainan 570311
  • China
+86 0898
Primary Industry
Pharmaceuticals
Stock Exchange
SHE
Vertical(s)
Corporate Office
  • No. 192, Nanhai Avenue
  • Xiuying District
  • Haikou, Hainan 570311
  • China
+86 0898

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hainan Haiyao Stock Performance

As of 13-Nov-2026, Hainan Haiyao’s stock price is $0.59. Its current market cap is $764M with 1.3B shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.59 $0.61 $0.53 - $1.30 $764M 1.3B 62.7M -$0.06

Hainan Haiyao Financials Summary

As of 30-Sep-2026, Hainan Haiyao has a trailing 12-month revenue of $97.6M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 1,258,776 1,668,018 1,222,075 1,238,973
Revenue 97,615 115,581 138,068 208,990
EBITDA (45,495) (3,430) (168,228) 27,564
Net Income (77,320) (59,793) (212,558) (15,052)
Total Assets 805,616 815,427 837,458 1,039,209
Total Debt 437,551 423,690 472,873 474,397
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Hainan Haiyao Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Hainan Haiyao‘s full profile, request access.

Request a free trial

Hainan Haiyao Patents

Hainan Haiyao Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2021164689-A1 Application of nelfinavir in preparation of drug for preventing and treating novel coronavirus pneumonia Inactive 17-Feb-2020

Hainan Haiyao Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hainan Haiyao Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Hainan Haiyao‘s full profile, request access.

Request a free trial

Hainan Haiyao Investments (4)

Hainan Haiyao’s most recent deal was a Early Stage VC with Unicar Therapy. The deal was made on 14-Jun-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Unicar Therapy 14-Jun-2019 Early Stage VC Biotechnology
Senyint International 29-Jan-2018 Later Stage VC Enterprise Systems (Healthcare)
Enjoy Health 01-Nov-2016 Early Stage VC Enterprise Systems (Healthcare)
Chenzhou First People's Hospital East Hospital 28-Jun-2016 Corporate Asset Purchase Buildings and Property
To view Hainan Haiyao’s complete investments history, request access »

Hainan Haiyao ESG

Risk Overview

Risk Rating

Updated April, 30, 2024

37.43 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,999

Rank

Percentile

Pharmaceuticals

Industry

of 952

Rank

Percentile

Pharmaceuticals

Subindustry

of 438

Rank

Percentile

To view Hainan Haiyao’s complete esg history, request access »

Hainan Haiyao Exits (1)

Hainan Haiyao’s most recent exit was on 01-Nov-2016 from Enjoy Health. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Enjoy Health 01-Nov-2016 Completed
To view Hainan Haiyao’s complete exits history, request access »

Hainan Haiyao Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Hainan Huantai Equity Investment Haikou, China 2013
Haiyao Enlarged Health Beijing, China

Hainan Haiyao FAQs

  • When was Hainan Haiyao founded?

    Hainan Haiyao was founded in 1965.

  • Where is Hainan Haiyao headquartered?

    Hainan Haiyao is headquartered in Haikou, China.

  • What is the size of Hainan Haiyao?

    Hainan Haiyao has 1,738 total employees.

  • What industry is Hainan Haiyao in?

    Hainan Haiyao’s primary industry is Pharmaceuticals.

  • Is Hainan Haiyao a private or public company?

    Hainan Haiyao is a Public company.

  • What is Hainan Haiyao’s stock symbol?

    The ticker symbol for Hainan Haiyao is 000566.

  • What is the current stock price of Hainan Haiyao?

    As of 13-Nov-2026 the stock price of Hainan Haiyao is $0.59.

  • What is the current market cap of Hainan Haiyao?

    The current market capitalization of Hainan Haiyao is $764M.

  • What is Hainan Haiyao’s current revenue?

    The trailing twelve month revenue for Hainan Haiyao is $97.6M.

  • What is Hainan Haiyao’s annual earnings per share (EPS)?

    Hainan Haiyao’s EPS for 12 months was -$0.06.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process